Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Alfa-1 Antitrypsinmangel

Research output: Contribution to journalReviewResearchpeer-review

  1. Kirurgisk behandling ved kvindelig infertilitet

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Surfactant therapy of respiratory distress syndrome

    Research output: Contribution to journalReviewResearchpeer-review

  3. DBCG Kvalitetsdatabase for Brystkræft – resumé af årsrapport 2020

    Research output: Contribution to journalJournal articleCommunication

  4. Nærdødsoplevelser

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Hjertestop hos en patient med langt QT-syndrom i androgendeprivationsterapi

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. First patient with ILNEB syndrome due to pathogenic variants in ITGA3 surviving to adulthood

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. The Association between Use of ICS and Psychiatric Symptoms in Patients with COPD—A Nationwide Cohort Study of 49,500 Patients

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Heart failure associated with imported malaria: a nationwide Danish cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Treatment Response Biomarkers in Asthma and COPD

    Research output: Contribution to journalReviewResearchpeer-review

View graph of relations

The subject of this review is alpha-1-antitrypsin deficiency (A1AD), which is a rare hereditary disease with great impact in adults, especially smokers, quality of life and longevity. Early diagnosis is crucial for treatment outcome. The primary care physician should refer patients younger than 50-years-old with COPD or emphysema, familiar accumulation of A1AD or liver cirrhosis of unknown cause. Most important treatment is smoking cessation, pulmonary rehabilitation and inhaled medication according to current guidelines. Substitution treatment with alpha-1-antitrypsin is now an option after its approval by the Danish medical council in January 2020.

Translated title of the contributionAlpha-1-antitrypsin deficiency
Original languageDanish
JournalUgeskrift for Laeger
Volume183
Issue number30
ISSN0041-5782
Publication statusPublished - 26 Jul 2021

ID: 67060931